Margaret Kaczor
Stock Analyst at William Blair
(0.53)
# 3,548
Out of 4,667 analysts
27
Total ratings
42.86%
Success rate
-11.08%
Average return
Main Sectors:
Stocks Rated by Margaret Kaczor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CBLL CeriBell | Initiates: Outperform | n/a | $25.06 | - | 1 | Nov 5, 2024 | |
| STIM Neuronetics | Downgrades: Market Perform | n/a | $0.80 | - | 4 | Aug 12, 2024 | |
| CVRX CVRx, Inc. | Downgrades: Market Perform | n/a | $13.52 | - | 2 | May 1, 2024 | |
| CUTR Cutera | Upgrades: Market Perform | n/a | $0.30 | - | 3 | Mar 22, 2024 | |
| INGN Inogen | Upgrades: Outperform | n/a | $9.46 | - | 5 | Feb 15, 2024 | |
| SKIN The Beauty Health Company | Downgrades: Market Perform | n/a | $1.49 | - | 2 | Nov 14, 2023 | |
| STAA STAAR Surgical Company | Downgrades: Market Perform | n/a | $26.32 | - | 1 | Jun 7, 2023 | |
| NVRO Nevro | Downgrades: Market Perform | n/a | $4.23 | - | 2 | Aug 5, 2021 | |
| DVA DaVita | Downgrades: Market Perform | n/a | $161.40 | - | 2 | Sep 11, 2019 | |
| MDT Medtronic | Assumes: Market Perform | n/a | $84.20 | - | 1 | Jun 6, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | n/a | $115.93 | - | 3 | Jan 25, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | n/a | $75.24 | - | 1 | Apr 27, 2017 |
CeriBell
Nov 5, 2024
Initiates: Outperform
Price Target: n/a
Current: $25.06
Upside: -
Neuronetics
Aug 12, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $0.80
Upside: -
CVRx, Inc.
May 1, 2024
Downgrades: Market Perform
Price Target: n/a
Current: $13.52
Upside: -
Cutera
Mar 22, 2024
Upgrades: Market Perform
Price Target: n/a
Current: $0.30
Upside: -
Inogen
Feb 15, 2024
Upgrades: Outperform
Price Target: n/a
Current: $9.46
Upside: -
The Beauty Health Company
Nov 14, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $1.49
Upside: -
STAAR Surgical Company
Jun 7, 2023
Downgrades: Market Perform
Price Target: n/a
Current: $26.32
Upside: -
Nevro
Aug 5, 2021
Downgrades: Market Perform
Price Target: n/a
Current: $4.23
Upside: -
DaVita
Sep 11, 2019
Downgrades: Market Perform
Price Target: n/a
Current: $161.40
Upside: -
Medtronic
Jun 6, 2018
Assumes: Market Perform
Price Target: n/a
Current: $84.20
Upside: -
Jan 25, 2018
Upgrades: Outperform
Price Target: n/a
Current: $115.93
Upside: -
Apr 27, 2017
Initiates: Outperform
Price Target: n/a
Current: $75.24
Upside: -